"That was 15 years ago. Davis has already survived three times longer than patients with even the best prognosis could have expected in the 20th century. The father of a son and two daughters when he was diagnosed, he has been able to watch those children grow up, take in a foster son, who is now 11, and see his first grandchild born.
And Davis is now part of a clinical trial of a targeted monoclonal antibody, daratumumab, that researchers hope will be a game changer in the treatment of myeloma. Even more amazing, Davis' story is becoming more and more common".
Læs mere her: http://www.curetoday.com/publications/cure/2015/hematology-2015/inching-toward-a-cure-for-multiple-myeloma/1
And Davis is now part of a clinical trial of a targeted monoclonal antibody, daratumumab, that researchers hope will be a game changer in the treatment of myeloma. Even more amazing, Davis' story is becoming more and more common".
Læs mere her: http://www.curetoday.com/publications/cure/2015/hematology-2015/inching-toward-a-cure-for-multiple-myeloma/1
